Pharmacyte Biotech Inc (OTCMKTS: PMCB)

Pharmacyte Biotech Inc. is a biotechnology company that focuses on developing treatments for brain cancer, pancreatic cancer, breast cancer, and diabetes through encapsulation technology using cellulose-based live cells. Through the company’s subsidiary, Medical Marijuana Sciences, Inc., Pharmacyte Biotech seeks to exploit the use of the technology in optimizing effectiveness of chemical constituents of marijuana, known as cannabinoids, against cancers.

The primary focus of Pharmacyte Biotech is on the advancement of treatment for advanced pancreatic cancer by combining the anti-cancer drug infosfamide with Cell-in-a-Box technology that converts infosfamide into its active, cancer-killing form. The company has completed ½ of their clinical trials in inoperable pancreatic cancer treatment, and in their research studies in diabetes treatment.  The company also distributes nutraceutical formulations and develops information technology for third parties.

The technology of live cell encapsulation used by Pharmacyte Biotech is a method of enclosing living cells, not drugs, in protective cocoons just about the size of a head of a pin. This technology, known as Cell-in-a-Box, can be classified as a platform upon which treatments for various indications can be developed, while eliminating or at least minimizing the ill side effects associated with other treatments. The company’s acquisition of rights for the Cell-in-a-Box technology for insulin-dependent diabetes has been completed.

Formerly known as eFoodSafety.com, Inc., the company changed its name to Nuvilex, Inc. in 2009. The company, which was founded in 1996, is based in Silver Spring, Maryland. The company manufactures and distributes various products, including Cinnergen, Cinnechol, Citroxin, Cinnsational, Cyclosurface, Infinitink, PurEffect, Talsyn, and Oraphyte.

Trading in the OTC markets under the symbol PMCB, Pharmacyte Biotech develops and prepares to commercialize diabetes and cancer treatments based upon a proprietary technology called Cell-in-a-Box. This cutting-edge technology provides the company, through its subsidiary Medical Marijuana Sciences, Inc., an opportunity to develop green approaches to combating deadly cancers that affect many people worldwide.


Yahoo! Finance: NVLX News

Latest Financial News for NVLX